232 related articles for article (PubMed ID: 21188549)
21. Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression.
Zhong JC; Yu XY; Lin QX; Li XH; Huang XZ; Xiao DZ; Lin SG
Br J Pharmacol; 2008 Jan; 153(1):66-74. PubMed ID: 17906677
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway.
Koka V; Huang XR; Chung AC; Wang W; Truong LD; Lan HY
Am J Pathol; 2008 May; 172(5):1174-83. PubMed ID: 18403595
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II increases fibronectin and collagen I through the β-catenin-dependent signaling in mouse collecting duct cells.
Cuevas CA; Gonzalez AA; Inestrosa NC; Vio CP; Prieto MC
Am J Physiol Renal Physiol; 2015 Feb; 308(4):F358-65. PubMed ID: 25411386
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.
Iekushi K; Taniyama Y; Kusunoki H; Azuma J; Sanada F; Okayama K; Koibuchi N; Iwabayashi M; Rakugi H; Morishita R
Hypertension; 2011 Aug; 58(2):190-6. PubMed ID: 21670418
[TBL] [Abstract][Full Text] [Related]
26. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.
Iwai M; Horiuchi M
Hypertens Res; 2009 Jul; 32(7):533-6. PubMed ID: 19461648
[TBL] [Abstract][Full Text] [Related]
27. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
28. The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells.
Hayashi N; Yamamoto K; Ohishi M; Tatara Y; Takeya Y; Shiota A; Oguro R; Iwamoto Y; Takeda M; Rakugi H
Hypertens Res; 2010 Nov; 33(11):1182-5. PubMed ID: 20703229
[TBL] [Abstract][Full Text] [Related]
29. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
Dilauro M; Zimpelmann J; Robertson SJ; Genest D; Burns KD
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1523-32. PubMed ID: 20357030
[TBL] [Abstract][Full Text] [Related]
30. Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.
Sukumaran V; Veeraveedu PT; Gurusamy N; Lakshmanan AP; Yamaguchi K; Ma M; Suzuki K; Nagata M; Takagi R; Kodama M; Watanabe K
Mol Cell Endocrinol; 2012 Apr; 351(2):208-19. PubMed ID: 22200414
[TBL] [Abstract][Full Text] [Related]
31. SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis.
Wang TN; Chen X; Li R; Gao B; Mohammed-Ali Z; Lu C; Yum V; Dickhout JG; Krepinsky JC
J Am Soc Nephrol; 2015 Aug; 26(8):1839-54. PubMed ID: 25398788
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice.
Oudit GY; Kassiri Z; Patel MP; Chappell M; Butany J; Backx PH; Tsushima RG; Scholey JW; Khokha R; Penninger JM
Cardiovasc Res; 2007 Jul; 75(1):29-39. PubMed ID: 17499227
[TBL] [Abstract][Full Text] [Related]
33. Angiotensin II-induced histone deacetylase 5 phosphorylation, nuclear export, and Egr-1 expression are mediated by Akt pathway in A10 vascular smooth muscle cells.
Truong V; Jain A; Anand-Srivastava MB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1543-H1554. PubMed ID: 33606583
[TBL] [Abstract][Full Text] [Related]
34. The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway.
Meng Y; Li T; Zhou GS; Chen Y; Yu CH; Pang MX; Li W; Li Y; Zhang WY; Li X
Antioxid Redox Signal; 2015 Jan; 22(3):241-58. PubMed ID: 25089563
[TBL] [Abstract][Full Text] [Related]
35. ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.
Singh N; Joshi S; Guo L; Baker MB; Li Y; Castellano RK; Raizada MK; Jarajapu YP
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1697-707. PubMed ID: 26386115
[TBL] [Abstract][Full Text] [Related]
36. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation.
Feng Y; Yue X; Xia H; Bindom SM; Hickman PJ; Filipeanu CM; Wu G; Lazartigues E
Circ Res; 2008 Mar; 102(6):729-36. PubMed ID: 18258853
[TBL] [Abstract][Full Text] [Related]
38. The ACE2-angiotensin-(1-7)-Mas axis protects against pancreatic cell damage in cell culture.
Wang J; Liu R; Qi H; Wang Y; Cui L; Wen Y; Li H; Yin C
Pancreas; 2015 Mar; 44(2):266-72. PubMed ID: 25426615
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II downregulates ACE2-mediated enhancement of MMP-2 activity in human cardiofibroblasts.
Kuan TC; Chen MY; Liao YC; Ko L; Hong YH; Yen CY; Hsieh WY; Cheng KS; Wu CL; Lin CS
Biochem Cell Biol; 2013 Dec; 91(6):435-42. PubMed ID: 24219285
[TBL] [Abstract][Full Text] [Related]
40. Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis.
Zhang J; Noble NA; Border WA; Huang Y
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F579-88. PubMed ID: 20032116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
